NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 8, 2024 $0.125 -4.12% $0.135 X 92.74% 0
JS JS Pro
Apr 4, 2024 $0.155 -5.49% $0.144 V 92.14% 1
Apr 4, 2024 $0.159 -3.02% $0.144 V 89.32% 1
JS JS Pro
Apr 3, 2024 $0.101 +0.60% $0.164 V 61.59% 1
Apr 3, 2024 $0.0977 -2.65% $0.164 X 59.59% 0
Apr 1, 2024 $0.101 -2.62% $0.0980 V 96.66% 1
Apr 1, 2024 Bullish $0.0980 X 0
JS JS Pro
Apr 1, 2024 $0.107 +2.88% $0.0980 X 90.82% 0
Mar 22, 2024 $0.0965 +5.46% $0.0915 X 94.54% 0
Mar 22, 2024 $0.0946 +3.41% $0.0915 X 96.59% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE